These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26631547)

  • 1. Leveraging a Multi-Omics Strategy for Prioritizing Personalized Candidate Mutation-Driver Genes: A Proof-of-Concept Study.
    Ding K; Wu S; Ying W; Pan Q; Li X; Zhao D; Li X; Zhao Q; Zhu Y; Ren H; Qian X
    Sci Rep; 2015 Dec; 5():17564. PubMed ID: 26631547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a multi-omics strategy for prioritizing personalized candidate driver genes.
    Liang L; Song L; Yang Y; Tian L; Li X; Wu S; Huang W; Ren H; Tang N; Ding K
    Oncotarget; 2016 Jun; 7(25):38440-38450. PubMed ID: 27469031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic sequencing identifies a few mutations driving the independent origin of primary liver tumors in a chronic hepatitis murine model.
    Yang Z; Jia M; Liu G; Hao H; Chen L; Li G; Liu S; Li Y; Wu CI; Lu X; Wang S
    PLoS One; 2017; 12(11):e0187551. PubMed ID: 29117265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma.
    Woo HG; Kim SS; Cho H; Kwon SM; Cho HJ; Ahn SJ; Park ES; Lee JS; Cho SW; Cheong JY
    PLoS One; 2014; 9(12):e115152. PubMed ID: 25521761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma.
    Löffler MW; Mohr C; Bichmann L; Freudenmann LK; Walzer M; Schroeder CM; Trautwein N; Hilke FJ; Zinser RS; Mühlenbruch L; Kowalewski DJ; Schuster H; Sturm M; Matthes J; Riess O; Czemmel S; Nahnsen S; Königsrainer I; Thiel K; Nadalin S; Beckert S; Bösmüller H; Fend F; Velic A; Maček B; Haen SP; Buonaguro L; Kohlbacher O; Stevanović S; Königsrainer A; ; Rammensee HG
    Genome Med; 2019 Apr; 11(1):28. PubMed ID: 31039795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.
    Ikeda A; Shimizu T; Matsumoto Y; Fujii Y; Eso Y; Inuzuka T; Mizuguchi A; Shimizu K; Hatano E; Uemoto S; Chiba T; Marusawa H
    Gastroenterology; 2014 Jan; 146(1):222-32.e35. PubMed ID: 24055508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma.
    Zhang G; Tang X; Liang L; Zhang W; Li D; Li X; Zhao D; Zheng Y; Chen Y; Hao B; Wang K; Tang N; Ding K
    Oncogene; 2020 Apr; 39(16):3229-3244. PubMed ID: 32071398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers.
    Shiraishi Y; Fujimoto A; Furuta M; Tanaka H; Chiba K; Boroevich KA; Abe T; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Shibuya T; Nakano K; Sasaki A; Maejima K; Kitada R; Hayami S; Shigekawa Y; Marubashi S; Yamada T; Kubo M; Ishikawa O; Aikata H; Arihiro K; Ohdan H; Yamamoto M; Yamaue H; Chayama K; Tsunoda T; Miyano S; Nakagawa H
    PLoS One; 2014; 9(12):e114263. PubMed ID: 25526364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma.
    Imbeaud S; Ladeiro Y; Zucman-Rossi J
    Semin Liver Dis; 2010 Feb; 30(1):75-86. PubMed ID: 20175035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
    Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
    Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
    Xue R; Li R; Guo H; Guo L; Su Z; Ni X; Qi L; Zhang T; Li Q; Zhang Z; Xie XS; Bai F; Zhang N
    Gastroenterology; 2016 Apr; 150(4):998-1008. PubMed ID: 26752112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide detection of allelic gene expression in hepatocellular carcinoma cells using a human exome SNP chip.
    Park YM; Cheong HS; Lee JK
    Gene; 2014 Nov; 551(2):236-42. PubMed ID: 25192659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas.
    Furukawa T; Sakamoto H; Takeuchi S; Ameri M; Kuboki Y; Yamamoto T; Hatori T; Yamamoto M; Sugiyama M; Ohike N; Yamaguchi H; Shimizu M; Shibata N; Shimizu K; Shiratori K
    Sci Rep; 2015 Mar; 5():8829. PubMed ID: 25743105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mutational landscape of hepatocellular carcinoma.
    Lee JS
    Clin Mol Hepatol; 2015 Sep; 21(3):220-9. PubMed ID: 26523267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma in patients from northern Sweden with acute intermittent porphyria: morphology and mutations.
    Bjersing L; Andersson C; Lithner F
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):393-7. PubMed ID: 9162306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome capture sequencing reveals new insights into hepatitis B virus-induced hepatocellular carcinoma at the early stage of tumorigenesis.
    Chen Y; Wang L; Xu H; Liu X; Zhao Y
    Oncol Rep; 2013 Oct; 30(4):1906-12. PubMed ID: 23912677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
    Lasorsa VA; Formicola D; Pignataro P; Cimmino F; Calabrese FM; Mora J; Esposito MR; Pantile M; Zanon C; De Mariano M; Longo L; Hogarty MD; de Torres C; Tonini GP; Iolascon A; Capasso M
    Oncotarget; 2016 Apr; 7(16):21840-52. PubMed ID: 27009842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Significant Regulatory Mutation Burden at a High-Affinity Position of the CTCF Motif in Gastrointestinal Cancers.
    Umer HM; Cavalli M; Dabrowski MJ; Diamanti K; Kruczyk M; Pan G; Komorowski J; Wadelius C
    Hum Mutat; 2016 Sep; 37(9):904-13. PubMed ID: 27174533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity.
    Shi JY; Xing Q; Duan M; Wang ZC; Yang LX; Zhao YJ; Wang XY; Liu Y; Deng M; Ding ZB; Ke AW; Zhou J; Fan J; Cao Y; Wang J; Xi R; Gao Q
    Oncotarget; 2016 Jan; 7(3):2867-77. PubMed ID: 26672766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.
    Nault JC; Fabre M; Couchy G; Pilati C; Jeannot E; Tran Van Nhieu J; Saint-Paul MC; De Muret A; Redon MJ; Buffet C; Salenave S; Balabaud C; Prevot S; Labrune P; Bioulac-Sage P; Scoazec JY; Chanson P; Zucman-Rossi J
    J Hepatol; 2012 Jan; 56(1):184-91. PubMed ID: 21835143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.